You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 84 No. 4, October 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Rate of Visual Loss in Behçet's Disease

Jubran G. Mamo, MD

Arch Ophthalmol. 1970;84(4):451-452.


Abstract

Vision in Behçet's disease is usually lost in an average of 3.36 years after onset of eye symptoms. These data may be helpful in assessing the effectiveness of any treatment used.



Author Affiliations

Beirut. Lebanon

From the Department of Ophthalmology, American University Hospital, Beirut, Lebanon.


Footnotes

Submitted for publication Jan 6, 1970.

Reprint requests to Department of Ophthalmology, American University Hospital, Beirut, Lebanon (Dr. Mamo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis et al.
Rheumatology (Oxford) 2007;46:736-741.
FULL TEXT  

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease
Triolo et al.
Ann Rheum Dis 2002;61:560-561.
FULL TEXT  

High dose intravenous steroid therapy for severe posterior segment uveitis in Behcet's disease
Toker et al.
Br J Ophthalmol 2002;86:521-523.
ABSTRACT | FULL TEXT  

Bilateral Acute Retinal Necrosis: Clinical and Ultrastructural Study
Topilow et al.
Arch Ophthalmol 1982;100:1901-1908.
ABSTRACT  

The Ocular Manifestations of Behcet's Disease
Colvard et al.
Arch Ophthalmol 1977;95:1813-1817.
ABSTRACT  

Treatment of Behcet Disease With Chlorambucil: A Follow-Up Report
Mamo
Arch Ophthalmol 1976;94:580-583.
ABSTRACT  

The Uvea
Schlaegel
Arch Ophthalmol 1971;85:624-635.
 

Treatment of Behcet's Disease With Chlorambucil
Mamo and Azzam
Arch Ophthalmol 1970;84:446-450.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.